K, T., C, D., S, M., C, L. T., D, D., & C, B. (2025). The Growth Modulation Index (GMI) as an Efficacy Outcome in Cancer Clinical Trials: A Scoping Review with Suggested Reporting Guidelines. Current oncology reports, 27(5), 516. https://doi.org/10.1007/s11912-025-01667-1
Chicago Style (17th ed.) CitationK, Trin, Dalleau C, Mathoulin-Pelissier S, Le Tourneau C, Dinart D, and Bellera C. "The Growth Modulation Index (GMI) as an Efficacy Outcome in Cancer Clinical Trials: A Scoping Review with Suggested Reporting Guidelines." Current Oncology Reports 27, no. 5 (2025): 516. https://doi.org/10.1007/s11912-025-01667-1.
MLA (9th ed.) CitationK, Trin, et al. "The Growth Modulation Index (GMI) as an Efficacy Outcome in Cancer Clinical Trials: A Scoping Review with Suggested Reporting Guidelines." Current Oncology Reports, vol. 27, no. 5, 2025, p. 516, https://doi.org/10.1007/s11912-025-01667-1.